Thomas Plitz
Chief Scientific Officer
Biochemistry
Wilson Therapeutics
Sweden
Biography
Education: M.Sc. Biology and Ph.D. Immunology and Cell Biology, Technical University of Munich. Other current assignments: – Previous assignments (last five years): Senior Director, R&D Product Strategy Lead of Shire AG and Director, Neurology Global Clinical Development of Merck Serono. Holdings in the Company: 1,500 ordinary shares, 150,500 stock options and 15,000 performance shares LTIP 2017.
Research Interest
Biotechnology, Biochemistry
